339 related articles for article (PubMed ID: 26997002)
1. Field randomized trial to evaluate the efficacy of the Leish-Tec® vaccine against canine visceral leishmaniasis in an endemic area of Brazil.
Regina-Silva S; Feres AM; França-Silva JC; Dias ES; Michalsky ÉM; de Andrade HM; Coelho EA; Ribeiro GM; Fernandes AP; Machado-Coelho GL
Vaccine; 2016 Apr; 34(19):2233-9. PubMed ID: 26997002
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis.
Fernandes CB; Junior JT; de Jesus C; Souza BM; Larangeira DF; Fraga DB; Tavares Veras PS; Barrouin-Melo SM
Vaccine; 2014 Mar; 32(11):1287-95. PubMed ID: 24406392
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses induced by Leish-Tec®, an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population.
Testasicca MC; dos Santos MS; Machado LM; Serufo AV; Doro D; Avelar D; Tibúrcio AM; Abrantes Cde F; Machado-Coelho GL; Grimaldi G; Gazzinelli RT; Fernandes AP
Vet Parasitol; 2014 Aug; 204(3-4):169-76. PubMed ID: 24863572
[TBL] [Abstract][Full Text] [Related]
4. Field trial of efficacy of the Leish-tec® vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates.
Grimaldi G; Teva A; Dos-Santos CB; Santos FN; Pinto ID; Fux B; Leite GR; Falqueto A
PLoS One; 2017; 12(9):e0185438. PubMed ID: 28953944
[TBL] [Abstract][Full Text] [Related]
5. Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis.
de Mendonça LZ; Resende LA; Lanna MF; Aguiar-Soares RD; Roatt BM; Castro RA; Batista MA; Silveira-Lemos D; Gomes Jde A; Fujiwara RT; Rezende SA; Martins-Filho OA; Corrêa-Oliveira R; Dutra WO; Reis AB; Giunchetti RC
Parasit Vectors; 2016 Aug; 9(1):472. PubMed ID: 27577735
[TBL] [Abstract][Full Text] [Related]
6. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
7. Dogs with divergent serology for visceral leishmaniasis as sources of Leishmania infection for Lutzomyia longipalpis phlebotomine sand flies - an observational study in an endemic area in Brazil.
Rocha MF; Michalsky ÉM; de Oliveira Lara-Silva F; Valadão JL; França-Silva JC; Pinheiro LC; de Sousa JF; Dos Santos RC; Soares MD; Fortes-Dias CL; Dias ES
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0008079. PubMed ID: 32078634
[TBL] [Abstract][Full Text] [Related]
8. A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.
Lage DP; Martins VT; Duarte MC; Costa LE; Garde E; Dimer LM; Kursancew AC; Chávez-Fumagalli MA; de Magalhães-Soares DF; Menezes-Souza D; Roatt BM; Machado-de-Ávila RA; Soto M; Tavares CA; Coelho EA
Parasitol Res; 2016 Apr; 115(4):1649-58. PubMed ID: 26782811
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.
Shahbazi M; Zahedifard F; Taheri T; Taslimi Y; Jamshidi S; Shirian S; Mahdavi N; Hassankhani M; Daneshbod Y; Zarkesh-Esfahani SH; Papadopoulou B; Rafati S
PLoS One; 2015; 10(7):e0132794. PubMed ID: 26197085
[TBL] [Abstract][Full Text] [Related]
10. Canine Leishmania vaccines: still a long way to go.
Gradoni L
Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
[TBL] [Abstract][Full Text] [Related]
11. High Performance of ELISA test using recombinant rLiNTPDase2 from Leishmania infantum: a Phase II diagnosis of Canine Visceral Leishmaniasis.
de Souza ACA; Castro RB; Dos Santos YL; Pavione NDRT; Agripino JM; Bahia MT; Machado-Coelho GLL; de Souza RF; de Oliveira LL; Souza CDSF; Bressan GC; Vasconcellos RS; de Almeida MR; Fietto JLR
Acta Trop; 2020 Sep; 209():105535. PubMed ID: 32450137
[TBL] [Abstract][Full Text] [Related]
12. Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas.
Palatnik-de-Sousa CB; Silva-Antunes I; Morgado Ade A; Menz I; Palatnik M; Lavor C
Vaccine; 2009 Jun; 27(27):3505-12. PubMed ID: 19464528
[TBL] [Abstract][Full Text] [Related]
13. Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.
Trigo J; Abbehusen M; Netto EM; Nakatani M; Pedral-Sampaio G; de Jesus RS; Goto Y; Guderian J; Howard RF; Reed SG
Vaccine; 2010 Apr; 28(19):3333-40. PubMed ID: 20206667
[TBL] [Abstract][Full Text] [Related]
14. Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosis.
Toepp A; Larson M; Wilson G; Grinnage-Pulley T; Bennett C; Leal-Lima A; Anderson B; Parrish M; Anderson M; Fowler H; Hinman J; Kontowicz E; Jefferies J; Beeman M; Buch J; Saucier J; Tyrrell P; Gharpure R; Cotter C; Petersen C
Vaccine; 2018 Oct; 36(43):6433-6441. PubMed ID: 30219369
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity assay of the Leishmune vaccine against canine visceral leishmaniasis in Brazil.
Borja-Cabrera GP; Santos FN; Bauer FS; Parra LE; Menz I; Morgado AA; Soares IS; Batista LM; Palatnik-de-Sousa CB
Vaccine; 2008 Sep; 26(39):4991-7. PubMed ID: 18675868
[TBL] [Abstract][Full Text] [Related]
16. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
[TBL] [Abstract][Full Text] [Related]
17. The diagnosis of canine visceral leishmaniasis in Brazil: Confronting old problems.
Pessoa-E-Silva R; Vaitkevicius-Antão V; de Andrade TAS; de Oliveira Silva AC; de Oliveira GA; Trajano-Silva LAM; Nakasone EKN; de Paiva-Cavalcanti M
Exp Parasitol; 2019 Apr; 199():9-16. PubMed ID: 30796913
[TBL] [Abstract][Full Text] [Related]
18. The mass use of deltamethrin collars to control and prevent canine visceral leishmaniasis: A field effectiveness study in a highly endemic area.
Leite BMM; Solcà MDS; Santos LCS; Coelho LB; Amorim LDAF; Donato LE; Passos SMS; Almeida AO; Veras PST; Fraga DBM
PLoS Negl Trop Dis; 2018 May; 12(5):e0006496. PubMed ID: 29758031
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal analysis of serological tests officially adopted by the Brazilian Ministry of Health for the diagnosis of canine visceral leishmaniasis in dogs vaccinated with Leishmune®.
Marcondes M; de Lima VM; de Araújo Mde F; Hiramoto RM; Tolezano JE; Vieira RF; Biondo AW
Vet Parasitol; 2013 Nov; 197(3-4):649-52. PubMed ID: 23920056
[TBL] [Abstract][Full Text] [Related]
20. LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.
Aguiar-Soares RD; Roatt BM; Ker HG; Moreira Nd; Mathias FA; Cardoso JM; Gontijo NF; Bruna-Romero O; Teixeira-Carvalho A; Martins-Filho OA; Corrêa-Oliveira R; Giunchetti RC; Reis AB
Parasit Vectors; 2014 Feb; 7():61. PubMed ID: 24507702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
